本帖最后由 风雨不动 于 2012-4-14 14:50 编辑
http://www.sciencedirect.com/science/article/pii/S0168827811007756
Research Article
Hepatitis B virus infection and fatty liver in the general population- Vincent Wai-Sun Wong1, 2,
- Grace Lai-Hung Wong1, 2,
- Winnie Chiu-Wing Chu1, 3, , ,
- Angel Mei-Ling Chim1, 2,
- Arlinking Ong1, 2, 4,
- David Ka-Wai Yeung5,
- Karen Kar-Lum Yiu1, 2,
- Shirley Ho-Ting Chu1, 2,
- Hoi-Yun Chan1, 2,
- Jean Woo2,
- Francis Ka-Leung Chan1, 2,
- Henry Lik-Yuen Chan1, 2, ,
- 1 Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong
- 2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong
- 3 Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong
- 4 Department of Medicine, Section of Gastroenterology, University of Santo Tomas Hospital, Espana Manila, Philippines
- 5 Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong
- Received 27 May 2011. Revised 23 August 2011. Accepted 21 September 2011. Available online 22 October 2011.
Background & AimsIn animal studies, expression of hepatitis B virus (HBV) proteins causes hepatic steatosis. We aimed to study the prevalence of fatty liver in people with and without HBV infection in the general population. MethodsWe performed a cross-sectional population study in Hong Kong Chinese. Intrahepatic triglyceride content (IHTG) was measured by proton-magnetic resonance spectroscopy. ResultsOne thousand and thirteen subjects (91 HBV patients and 922 controls) were recruited. The median IHTG was 1.3% (0.2–33.3) in HBV patients and 2.1% (0–44.2) in controls (p <0.001). Excluding subjects with significant alcohol consumption, the prevalence of nonalcoholic fatty liver disease was 13.5% (95% confidence interval [CI] 6.4%, 20.6%) in HBV patients and 28.3% (95% CI 25.3%, 31.2%) in controls (p = 0.003). The fatty liver prevalence differed in HBV patients and controls aged 40–59 years but was similar in those aged 60 years or above. After adjusting for demographic and metabolic factors, HBV infection remained an independent factor associated with lower risk of fatty liver (adjusted odds ratio 0.42; 95% CI 0.20, 0.88; p = 0.022). HBV patients also had a lower prevalence of metabolic syndrome (11.0% vs. 20.2%; p = 0.034), but the difference was mainly attributed to lower triglyceride levels. Among HBV patients, viral genotypes, HBV DNA level and hepatitis B e antigen status were not associated with fatty liver. ConclusionsHBV infection is associated with a lower prevalence of fatty liver, hypertriglyceridemia and metabolic syndrome. Viral replication may affect lipid metabolism and this warrants further studies.
Abbreviations- Anti-HBe, antibody against hepatitis B e antigen;
- CI, confidence interval;
- HBeAg, hepatitis B e antigen;
- HBV, hepatitis B virus;
- HBx, hepatitis B X;
- NAFLD, nonalcoholic fatty liver disease;
- 1H-MRS, proton-magnetic resonance spectroscopy
Keywords- Nonalcoholic fatty liver disease;
- Nonalcoholic steatohepatitis;
- Obesity;
- Diabetes mellitus;
- Hypertriglyceridemia;
- Cross-sectional study
(6.合.彩)足球.篮球...各类投注开户下注
第一投注现金网:招代理年薪10万以上:yyu.cc |